4.99
price up icon3.31%   0.16
after-market Dopo l'orario di chiusura: 4.88 -0.11 -2.20%
loading
Precedente Chiudi:
$4.83
Aprire:
$4.82
Volume 24 ore:
384.96K
Relative Volume:
1.26
Capitalizzazione di mercato:
$288.54M
Reddito:
-
Utile/perdita netta:
$-40.33M
Rapporto P/E:
-0.8358
EPS:
-5.97
Flusso di cassa netto:
$-39.53M
1 W Prestazione:
+39.00%
1M Prestazione:
+90.46%
6M Prestazione:
+107.05%
1 anno Prestazione:
+305.69%
Intervallo 1D:
Value
$4.7577
$5.38
Intervallo di 1 settimana:
Value
$3.50
$5.54
Portata 52W:
Value
$1.07
$5.54

Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile

Name
Nome
Eledon Pharmaceuticals Inc
Name
Telefono
949-238-8090
Name
Indirizzo
19800 MACARTHUR BLVD., IRVINE
Name
Dipendente
20
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ELDN's Discussions on Twitter

Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-05-13 Ripresa Cantor Fitzgerald Overweight
2021-03-23 Iniziato Cantor Fitzgerald Overweight

Eledon Pharmaceuticals Inc Borsa (ELDN) Ultime notizie

pulisher
Oct 31, 2024

Biotechnology Value Fund L P's Strategic Acquisition in Eledon P - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

ELDN stock touches 52-week high at $4.13 amid robust gains - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

ELDN stock touches 52-week high at $4.13 amid robust gains By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

SEC Form 424B5 filed by Eledon Pharmaceuticals Inc. - Quantisnow

Oct 30, 2024
pulisher
Oct 30, 2024

Eledon drug helps transplants 'cure' type 1 diabetes - pharmaphorum

Oct 30, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals sets terms for $85 million stock offering By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon: Changing Scope Of Immunosuppressive Drug Space With Tegoprubart (ELDN) - Seeking Alpha

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Shares Hit 52-Week High After Positive Trial Data - MarketWatch

Oct 29, 2024
pulisher
Oct 29, 2024

Promising results for diabetes treatment with new drug By Investing.com - Investing.com Australia

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals sets terms for $85 million stock offering - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine - The Manila Times

Oct 29, 2024
pulisher
Oct 29, 2024

Promising results for diabetes treatment with new drug - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Pricing of $85 Million - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Positive Initial Data from - GlobeNewswire

Oct 29, 2024
pulisher
Oct 29, 2024

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - StockTitan

Oct 29, 2024
pulisher
Oct 26, 2024

Algorae Pharmaceuticals Plans Major Securities Issuance - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

Midday Stock Roundup: The Ensign Group Beats Q3 Expectations - Orange County Business Journal

Oct 25, 2024
pulisher
Oct 23, 2024

ELDN stock soars to 52-week high, touches $3.35 amid surge - Investing.com

Oct 23, 2024
pulisher
Oct 23, 2024

ELDN stock soars to 52-week high, touches $3.35 amid surge By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 04, 2024

Financial Analysis: Eledon Pharmaceuticals (NASDAQ:ELDN) & ABVC BioPharma (NASDAQ:ABVC) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

IgA nephropathy Clinical Trials 2024 (Updated): FDA Approvals, - openPR

Oct 03, 2024
pulisher
Oct 01, 2024

Eledon Pharmaceuticals completes $4 million equity sale - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Eledon Pharmaceuticals completes $4 million equity sale By Investing.com - Investing.com South Africa

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Invests $1.58 Million in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Nantahala Capital Management LLC Acquires New Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - MarketBeat

Oct 01, 2024
pulisher
Sep 28, 2024

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Short Interest Update - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Midday Stock Roundup: STAAR Surgical CO. Shares Surge 22% - Orange County Business Journal

Sep 27, 2024
pulisher
Sep 20, 2024

Eledon Pharmaceuticals initiates $75 million stock sale agreement By Investing.com - Investing.com Australia

Sep 20, 2024
pulisher
Sep 20, 2024

Eledon Pharmaceuticals initiates $75 million stock sale agreement - Investing.com

Sep 20, 2024
pulisher
Sep 11, 2024

Eledon Pharmaceuticals to Present at the Cantor Global Healthcare Conference - GlobeNewswire

Sep 11, 2024
pulisher
Sep 04, 2024

ELDNEledon Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

Eledon Announces Completion of Enrollment in Phase 2 BESTOW - GlobeNewswire

Sep 04, 2024
pulisher
Sep 04, 2024

Eledon Announces Completion of Enrollment in Phase 2 BESTOW Clinical Trial Assessing Tegoprubart for Prevention of Organ Rejection in Kidney Transplant Patients - StockTitan

Sep 04, 2024
pulisher
Sep 02, 2024

Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Declines By 6.8% - MarketBeat

Sep 02, 2024
pulisher
Aug 23, 2024

Analysts Issue Forecasts for Eledon Pharmaceuticals, Inc.'s Q3 2024 Earnings (NASDAQ:ELDN) - MarketBeat

Aug 23, 2024
pulisher
Aug 23, 2024

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Expected to Earn Q3 2024 Earnings of ($0.20) Per Share - Defense World

Aug 23, 2024
pulisher
Aug 20, 2024

Vanguard Group Inc. Has $2 Million Stock Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - MarketBeat

Aug 20, 2024
pulisher
Aug 19, 2024

S&P 500 Information Technology [Sector] (SRIT) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

TSX Consumer Discretionary Capped Index (TTCD) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

2 'Strong Buy'-Rated Stocks That Wall Street Believes Can Soar Over 360% - TradingView

Aug 19, 2024
pulisher
Aug 19, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 19, 2024

Eledon Pharmaceuticals Inc (ELDN-Q) QuotePress Release - The Globe and Mail

Aug 19, 2024
pulisher
Aug 14, 2024

Eledon Expects to Restate Results, Delays Quarterly Report - MarketWatch

Aug 14, 2024
pulisher
Aug 14, 2024

Eledon Pharmaceuticals Reports Preliminary Second Quarter 2024 Operating Results - GlobeNewswire

Aug 14, 2024
pulisher
Aug 02, 2024

Eledon Pharmaceuticals (NASDAQ:ELDN) Stock Price Down 1.7% - MarketBeat

Aug 02, 2024
pulisher
Aug 02, 2024

Eledon Pharmaceuticals (NASDAQ:ELDN) Shares Down 1.7% - Defense World

Aug 02, 2024
pulisher
Jul 29, 2024

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial - GlobeNewswire

Jul 29, 2024
pulisher
Jul 29, 2024

Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection - Yahoo Finance

Jul 29, 2024
pulisher
Jul 26, 2024

Midday Stock Roundup: BJ’s Drops on Revenue Miss - Orange County Business Journal

Jul 26, 2024
pulisher
Jul 24, 2024

4 High-Risk, High-Reward Small-Cap Stocks to Play the Rotation - Investing.com

Jul 24, 2024

Eledon Pharmaceuticals Inc Azioni (ELDN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):